Literature DB >> 7586774

A modified version of the Health Assessment Questionnaire (HAQ) for psoriatic arthritis.

J A Husted1, D D Gladman, J A Long, V T Farewell.   

Abstract

OBJECTIVE: The purpose of the present investigation was to explore a modification of the Health Assessment Questionnaire (HAQ) to capture the functional problems associated with psoriasis as well as inflammatory arthritis in patients with psoriatic arthritis (PsA).
METHODS: During a visit to the Psoriatic Arthritis Clinic, 118 patients with PsA were asked to complete the modified version of the HAQ. The original HAQ and expanded HAQ (HAQ-SK) scores were calculated. Correlation and regression analyses were used to examine the relationship between the severity of psoriasis and the functional status as measured by the various HAQ measures.
RESULTS: The mean global HAQ score was 0.55 on a scale ranging from 0 to 3, while the mean global HAQ-SK score was 0.56, suggesting that the modification, which involved adding items to reflect those aspects of physical functioning most affected by psoriasis, did not materially change the global HAQ score. There were no significant associations between the global HAQ-SK disability score or the added psoriasis items and the severity and activity of psoriasis, as measured by the Psoriasis Area and Severity Index (PASI) (all correlations < 0.20). The only significant association was found between the patient and the clinician ratings of psoriasis severity (r = 0.49). Open-ended questions suggest that psychosocial functioning is another dimension of health status which is of concern to PsA patients.
CONCLUSION: The findings suggest that physical disabilities associated with the severity and activity of psoriasis are not captured by the HAQ or the HAQ-SK. Psychosocial functioning, an additional area of concern to PsA patients, is also not directly linked to physical functioning or to the severity of psoriasis.

Entities:  

Mesh:

Year:  1995        PMID: 7586774

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  17 in total

Review 1.  Clinical, radiological, and functional assessment in psoriatic arthritis: is it different from other inflammatory joint diseases?

Authors:  D D Gladman
Journal:  Ann Rheum Dis       Date:  2006-11       Impact factor: 19.103

2.  Relationship between psoriatic arthritis and moderate-severe psoriasis: analysis of a series of 166 psoriatic arthritis patients selected from a hospital population.

Authors:  Noemi Busquets-Pérez; Jesus Rodriguez-Moreno; Carmen Gómez-Vaquero; Joan M Nolla-Solé
Journal:  Clin Rheumatol       Date:  2011-06-24       Impact factor: 2.980

3.  Adalimumab improves joint-related and skin-related functional impairment in patients with psoriatic arthritis: patient-reported outcomes of the Adalimumab Effectiveness in Psoriatic Arthritis Trial.

Authors:  D D Gladman; P J Mease; M A Cifaldi; R J Perdok; E Sasso; J Medich
Journal:  Ann Rheum Dis       Date:  2006-10-17       Impact factor: 19.103

Review 4.  Management of psoriatic arthritis from the view of the dermatologist.

Authors:  Caroline A Chang; Alice B Gottlieb; Paul F Lizzul
Journal:  Nat Rev Rheumatol       Date:  2011-09-13       Impact factor: 20.543

Review 5.  Psoriatic arthritis: epidemiology, clinical features, course, and outcome.

Authors:  D D Gladman; C Antoni; P Mease; D O Clegg; P Nash
Journal:  Ann Rheum Dis       Date:  2005-03       Impact factor: 19.103

Review 6.  Psoriatic arthritis clinical registries and genomics.

Authors:  D D Gladman; C Ritchlin; P S Helliwell
Journal:  Ann Rheum Dis       Date:  2005-03       Impact factor: 19.103

Review 7.  Psoriatic arthritis assessment tools in clinical trials.

Authors:  P J Mease; C E Antoni; D D Gladman; W J Taylor
Journal:  Ann Rheum Dis       Date:  2005-03       Impact factor: 19.103

8.  Treatment of refractory psoriatic arthritis with infliximab: a 12 month observational study of 16 patients.

Authors:  M Feletar; J E Brockbank; C T Schentag; V Lapp; D D Gladman
Journal:  Ann Rheum Dis       Date:  2004-02       Impact factor: 19.103

9.  Development of the PsAQoL: a quality of life instrument specific to psoriatic arthritis.

Authors:  S P McKenna; L C Doward; D Whalley; A Tennant; P Emery; D J Veale
Journal:  Ann Rheum Dis       Date:  2004-02       Impact factor: 19.103

Review 10.  Economic burden of psoriatic arthritis.

Authors:  Christoph Ackermann; Arthur Kavanaugh
Journal:  Pharmacoeconomics       Date:  2008       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.